SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis
Authors
Keywords
-
Journal
EXPERIMENTAL DERMATOLOGY
Volume 27, Issue 6, Pages 641-646
Publisher
Wiley
Online
2018-03-03
DOI
10.1111/exd.13523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells
- (2017) Chiyuki Ueshima et al. Cancer Medicine
- SLAM family receptors in normal immunity and immune pathologies
- (2016) Ning Wu et al. CURRENT OPINION IN IMMUNOLOGY
- NKp46 regulates the production of serine proteases and IL-22 in human mast cells in urticaria pigmentosa
- (2015) Chiyuki Ueshima et al. EXPERIMENTAL DERMATOLOGY
- The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion
- (2015) C. Ueshima et al. Cancer Immunology Research
- Migration of Myeloid Cells during Inflammation Is Differentially Regulated by the Cell Surface Receptors Slamf1 and Slamf8
- (2015) Guoxing Wang et al. PLoS One
- Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice
- (2015) Namit Sharma et al. Oncotarget
- Siglec-7 is an inhibitory receptor on human mast cells and basophils
- (2014) Sa'ar Mizrahi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- PD-1 Regulates the Growth of Human Mastocytosis Cells
- (2013) Tatsuki R. Kataoka et al. ALLERGOLOGY INTERNATIONAL
- Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT
- (2012) R. S. Mali et al. BLOOD
- Cutting Edge: Slamf8 Is a Negative Regulator of Nox2 Activity in Macrophages
- (2012) G. Wang et al. JOURNAL OF IMMUNOLOGY
- Oncogenic Kit Triggers Shp2/Erk1/2 Pathway to Down-Regulate the Pro-Apoptotic Protein Bim and to Promote Apoptosis Resistance in Leukemic Cells
- (2012) Dorothée Selimoglu-Buet et al. PLoS One
- Novel Identified Receptors on Mast Cells
- (2012) Helena Migalovich-Sheikhet et al. Frontiers in Immunology
- CD84 Negatively Regulates IgE High-Affinity Receptor Signaling in Human Mast Cells
- (2011) D. Alvarez-Errico et al. JOURNAL OF IMMUNOLOGY
- CD72 Negatively Regulates KIT-Mediated Responses in Human Mast Cells
- (2010) Tatsuki R. Kataoka et al. JOURNAL OF IMMUNOLOGY
- An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E–mediated immediate hypersensitivity reactions
- (2010) Kaori Hitomi et al. NATURE IMMUNOLOGY
- An Activating and Inhibitory Signal from an Inhibitory Receptor LMIR3/CLM-1: LMIR3 Augments Lipopolysaccharide Response through Association with FcR in Mast Cells
- (2009) K. Izawa et al. JOURNAL OF IMMUNOLOGY
- Mast cells and mastocytosis
- (2008) D. D. Metcalfe BLOOD
- Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders
- (2008) B M Jensen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking
- (2008) K. Hellmuth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started